Ozempic / GLP-1 Lawsuits
FDA Flags GLP-1 Pens That May Contain No Medication; New Research Examines Additional Risks
Published Updated
By People's Justice
What happened
According to a report from MedShadow Foundation, the FDA issued a warning that some GLP-1 receptor agonist pens may contain no medication. The report was published alongside separate coverage of ongoing gastroparesis litigation and new peer-reviewed research examining GLP-1 drugs and bipolar disorder hospitalization, pregnancy complications, and orofacial adverse events.
Event date:
Source: news.google.com